Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer… - …, 2021 - Taylor & Francis
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

[HTML][HTML] Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer… - …, 2021 - ncbi.nlm.nih.gov
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

[PDF][PDF] Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer, JG Pol - 2021 - researchgate.net
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer… - …, 2021 - hal.science
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi… - …, 2021 - hal.sorbonne-universite.fr
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

Trial watch: intratumoral immunotherapy.

J Humeau, J Le Naour, L Galluzzi, G Kroemer… - …, 2021 - europepmc.org
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi… - …, 2021 - pubmed.ncbi.nlm.nih.gov
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …

[PDF][PDF] Trial watch: intratumoral immunotherapy

J Humeau, J Le Naour, L Galluzzi, G Kroemer, JG Pol - 2021 - hal.sorbonne-universite.fr
While chemotherapy and radiotherapy remain the first-line approaches for the management
of most unresectable tumors, immunotherapy has emerged in the past two decades as a …